To receive your instant CME/CE certificate, you must first "Sign In" or "Sign Up" in the top right corner.
RELEASE DATE: July 24, 2020
EXPIRATION DATE: July 31, 2021, for CME credit; June 8, 2023, for COPE credit
MAXIMUM CREDITS: 1.25 AMA PRA Category 1 Credits™ or 1.25 COPE CE credits
CLICK BELOW TO PROCEED TO PROGRAM
LEARNING METHOD AND MEDIUM
This educational activity consists of a webcast and thirteen (13) study questions. The participant should, in order, read the learning objectives, complete the pretest, view the webcast, answer all questions in the post test, and complete the evaluation. To receive credit for this activity, please complete the post test and evaluation. This educational activity should take a maximum of 1.25 hours to complete.
PROGRAM OVERVIEW
Neurotrophic keratitis (NK) is characterized by disrupted tearing and progressive corneal damage that does not readily heal. Until very recently, a lack of effective treatment to reinnervate and heal eyes affected by NK served to further hamper efforts toward timely diagnosis. Now that an effective treatment is available, ophthalmologists and optometrists need to identify patients who might benefit from treatment before the disease progresses to the point of corneal perforation and subsequent loss of visual acuity. The desired results of this educational activity are for ophthalmologists and optometrists to have a better understanding of the pathophysiology of NK as well as current best practices for screening, diagnosis, and treatment.
INSTRUCTIONS FOR OBTAINING CREDIT
To obtain CME/CE credit for this activity, please view the webcast, consult referenced sources as necessary, and complete the post test and evaluation online. Upon passing with a score of 70% or higher, a certificate will be made available immediately.
This continuing medical education activity is provided by MedEdicus LLC.
COPE
approved for 1.25 CE credits for optometrists.
COPE Course ID: 68282-AS
COPE Course Category: Treatment & Management of Ocular Disease: Anterior Segment (AS)
Administrator:
This continuing medical education activity is supported through an unrestricted educational grant from Dompé US, Inc.